Emergency Medical Director’s Association of California (EMDAC) Supraglottic Airway Device (SAD) Policy Development Guide *Note: This is intended to provide advisement to interested LEMSA medical directors who wish to pursue implementing SADs as part of their local optional scope. Use: Securing and maintaining a patent airway during resuscitation of the unconscious patient, by personnel who are trained and experienced in the use of airway management techniques and devices. Medical Control Offline medical control for SAD use in all patients Retrospective evaluation of system performance using SADs, in addition to quality assurance of SAD use should be overseen by LEMSA medical director Treatment Protocols Key Elements must include, but are not limited to, the following: Indications Rescue airway if unable to intubate an adult patient in need of airway protection Primary airway if intubation in an adult patient is anticipated to be difficult and rapid airway control is necessary Primary airway in adult cardiac arrest when attempts at intubation are likely to interrupt continuous chest compressions Preferred advanced airway in pediatric patients Contraindications Intact gag reflex Caustic ingestion Unresolved complete airway obstruction Trismus or limited ability to open the mouth Oral trauma ropharyngeal mass Procedure (LEMSA preference for format; device specific) Quality assurance 100% audit of all SAD uses will be performed by ALS provider’s Quality Care/Clinical Coordinator. Monthly reports filed with the LEMSA following the approved SAD data tracking/reporting form Comprehensive and expeditious review by the LEMSA of unanticipated complications or untoward events involving the use of a SAD
Emergency Medical Director’s Association of California (EMDAC) Supraglottic Airway Device (SAD) Policy Development Guide *Note: This is intended to provide advisement to interested LEMSA medical directors who wish to pursue implementing SADs as part of their local optional scope. Use: Securing and maintaining a patent airway during resuscitation of the unconscious patient, by personnel who are trained and experienced in the use of airway management techniques and devices. Medical Control Offline medical control for SAD use in all patients Retrospective evaluation of system performance using SADs, in addition to quality assurance of SAD use should be overseen by LEMSA medical director Treatment Protocols Key Elements must include, but are not limited to, the following: Indications Rescue airway if unable to intubate an adult patient in need of airway protection Primary airway if intubation in an adult patient is anticipated to be difficult and rapid airway control is necessary Primary airway in adult cardiac arrest when attempts at intubation are likely to interrupt continuous chest compressions Preferred advanced airway in pediatric patients Contraindications Intact gag reflex Caustic ingestion Unresolved complete airway obstruction Trismus or limited ability to open the mouth Oral trauma ropharyngeal mass Procedure (LEMSA preference for format; device specific) Quality assurance 100% audit of all SAD uses will be performed by ALS provider’s Quality Care/Clinical Coordinator. Monthly reports filed with the LEMSA following the approved SAD data tracking/reporting form Comprehensive and expeditious review by the LEMSA of unanticipated complications or untoward events involving the use of a SAD
Mountain-Valley_Policy_Development_Guide-v3.docx